← Eichor
Study identifier: NCT06282939 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry

Condition: Intracranial Aneurysm  ·  Sponsor: HCA Healthcare Research Institute

PhaseN/A
Planned participants600
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a prospective, open-label, consecutive enrollment, multi-center, U.S. registry of patients with intracranial aneurysms who are treated with the Optima Coil System. The primary objective of this registry is to evaluate the safety and effectiveness of the OptimaTM Coil System, including the OptiMAX Coils, in the real-world treatment of intracranial aneurysms. Imaging will be analyzed by a designated core neuroimaging lab to assess procedural success and aneurysm occlusion rates. Intent to treat population total: 700 patients 600 patients, up to 100 screen failures.

This description comes directly from the study's public registry record.

Talk to the study team

Allison Kiser  ·  812-617-5328  ·  allison.kiser@hcahealthcare.com

Gina Remington  ·  352-745-0055  ·  gina.remington@hcahealthcare.com

Always discuss trial participation with your own doctor first.

Locations (1)

Med City PlanoPlano, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06282939